全文获取类型
收费全文 | 17196篇 |
免费 | 723篇 |
国内免费 | 137篇 |
专业分类
耳鼻咽喉 | 177篇 |
儿科学 | 362篇 |
妇产科学 | 124篇 |
基础医学 | 2169篇 |
口腔科学 | 307篇 |
临床医学 | 1112篇 |
内科学 | 4620篇 |
皮肤病学 | 444篇 |
神经病学 | 1384篇 |
特种医学 | 556篇 |
外科学 | 2730篇 |
综合类 | 48篇 |
一般理论 | 4篇 |
预防医学 | 376篇 |
眼科学 | 619篇 |
药学 | 1126篇 |
中国医学 | 28篇 |
肿瘤学 | 1870篇 |
出版年
2024年 | 14篇 |
2023年 | 106篇 |
2022年 | 265篇 |
2021年 | 451篇 |
2020年 | 219篇 |
2019年 | 281篇 |
2018年 | 350篇 |
2017年 | 276篇 |
2016年 | 371篇 |
2015年 | 415篇 |
2014年 | 512篇 |
2013年 | 621篇 |
2012年 | 1103篇 |
2011年 | 1159篇 |
2010年 | 689篇 |
2009年 | 587篇 |
2008年 | 1020篇 |
2007年 | 1161篇 |
2006年 | 1076篇 |
2005年 | 1224篇 |
2004年 | 1202篇 |
2003年 | 1055篇 |
2002年 | 1105篇 |
2001年 | 205篇 |
2000年 | 153篇 |
1999年 | 230篇 |
1998年 | 289篇 |
1997年 | 210篇 |
1996年 | 216篇 |
1995年 | 188篇 |
1994年 | 163篇 |
1993年 | 171篇 |
1992年 | 105篇 |
1991年 | 86篇 |
1990年 | 96篇 |
1989年 | 82篇 |
1988年 | 64篇 |
1987年 | 43篇 |
1986年 | 43篇 |
1985年 | 41篇 |
1984年 | 43篇 |
1983年 | 38篇 |
1982年 | 45篇 |
1981年 | 40篇 |
1980年 | 32篇 |
1979年 | 31篇 |
1978年 | 35篇 |
1977年 | 26篇 |
1976年 | 12篇 |
1975年 | 13篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
111.
112.
Taro Semba Yasuhiro Funahashi Naoto Ono Yuji Yamamoto Naoko Hata Sugi Makoto Asada Kentaro Yoshimatsu Toshiaki Wakabayashi 《Clinical cancer research》2004,10(4):1430-1438
We reported previously that an angiogenesis inhibitor, E7820, inhibits in vitro tube formation of human umbilical vein endothelial cell through the suppression of integrin alpha2 expression. Here we describe the antiangiogenic and antitumor effects of E7820 in mice and discuss the feasibility of using platelet integrin alpha2 expression on platelets as a biological marker of the efficacy of E7820. Oral administration of E7820 significantly inhibited basic fibroblast growth factor-induced angiogenesis in Matrigel implants and human colon WiDr tumor-induced angiogenesis in a dorsal air sac model. Twice-daily treatment with E7820 clearly inhibited the s.c. tumor growth of seven tumor cell lines derived from human colon, breast, pancreas, and kidney, and completely suppressed the growth of human pancreatic KP-1 and human colon LoVo cell lines. Moreover, E7820 significantly inhibited the growth of KP-1 and human colon tumor Colo320DM cells orthotopically implanted in the pancreas and cecum, respectively. The efficacy of E7820 was comparable in the s.c. and orthotopic transplantation models. Immunohistochemical analyses using anti-CD31 antibody showed that E7820 significantly reduced microvessel density in orthotopically implanted KP-1 tumor. E7820 reduced integrin alpha2 expression on a megakaryocytic cell line, Dami cells, induced by phorbol 12-myristate 13-acetate treatment. It also decreased the expression level of integrin alpha2 on platelets withdrawn from mice bearing s.c. KP-1 tumor at a dosage close to that affording antitumor activity. These data demonstrate that E7820 showed a broad-spectrum antitumor effect in mice through inhibition of angiogenesis and indicate that the decrease of integrin alpha2 on platelets might serve as a biological marker for the antitumor efficacy of E7820. 相似文献
113.
114.
Intensification of antitumor effect by T helper 1-dominant adoptive immunogene therapy for advanced orthotopic colon cancer. 总被引:11,自引:0,他引:11
Mikihito Nakamori Makoto Iwahashi Masaki Nakamura Kentaro Ueda Xiaoliu Zhang Hiroki Yamaue 《Clinical cancer research》2003,9(6):2357-2365
PURPOSE: T helper (Th) 1/Th2 balance, controlled by Th1 or Th2 cells producing cytokines, plays important roles in antitumor immunity. Interleukin-18 (IL-18) can act together with IL-12 in promoting the generation of IFN-gamma producing Th1 cells. The goal of this study was to determine whether cytotoxic T lymphocyte (CTL) secreted in a murine IL-18-induced Th1-dominant state inhibited the development of primary tumors and synchronous liver metastases in orthotopic colon cancer model. EXPERIMENTAL DESIGN: Murine IL-18 gene was transduced into activated T lymphocytes by an adenovirus vector encoding IL-18 (AdIL-18) liposome complex method. Efficacy of adoptive immunogene therapy using AdIL-18 with or without IL-12 was tested in advanced orthotopic xenograft of murine colon cancer. To elucidate the mechanism responsible for the adoptive immunogene therapy, serum IL-4, IL-6, IFN-gamma, and tumor necrosis factor alpha production in Th1/Th2 cytokine balance and quantification of tumor vascularity were investigated. RESULTS: By a modified method of adenoviral gene transduction, T lymphocytes achieved efficient IL-18 production without cell toxicity. Against orthotopic colon cancer, when combined with low dose of recombinant (r) IL-12 (AdIL-18-CTL/rIL-12), the therapeutic efficacy showed much smaller tumors with no liver metastases and no disseminated tumors. There was a significant difference in the volume of primary tumors and the number of liver metastases compared with the group treated with AdIL-18-CTL alone or other group (P < 0.01). In addition, the median survival time of the group treated with AdIL-18-CTL was 53.7 +/- 5.8 days and that of AdIL-18-CTL/rIL-12 was 78.4 +/- 6.1 days, which was also a significant difference (P < 0.01). These antitumor mechanisms were involved with Th1-dominant response in serum Th1/Th2 cytokine balance and suppression of neovascularization at primary tumor site. CONCLUSION: These data suggest that a strategy of Th1/Th2 balance-based adoptive immunogene therapy might be useful for advanced cancer patients. 相似文献
115.
Tetsuro Higuchi Takeo Iwama Keigo Yoshinaga Masahiro Toyooka Makoto M Taketo Kenichi Sugihara 《Clinical cancer research》2003,9(13):4756-4760
PURPOSE: The aim of this study was to examine the effect of a specific cyclooxygenase-2 inhibitor, rofecoxib, on rectal polyps in familial adenomatous polyposis patients. EXPERIMENTAL DESIGN: This was a randomized, double-blind, placebo-controlled study of the efficacy and safety of rofecoxib in the rectum. Initially, 21 patients were assigned randomly in a 1:1 ratio to receive either 25 mg rofecoxib once a day or a placebo p.o. for 9 months. Patients underwent endoscopy at the beginning of the study and then every 3 months thereafter. We reviewed the videotapes to measure the number and size of polyps in the same area throughout the study period in each individual patient. RESULTS: The polyp number, measured as the percentage of change from the baseline values, was significantly decreased in the rofecoxib group at 3, 6, and 9 months. At 9 months, the polyp number in the rofecoxib group decreased by 6.8% from the baseline values, whereas that in the placebo group increased by 3.1%. The 9.9% difference between the rofecoxib and placebo groups was statistically significant (P = 0.004). At 9 months, the rofecoxib group showed a significant reduction from the baseline in polyp size as compared with the placebo group (-16.2% versus 1.5%; P < 0.001). There was no statistically significant increase in the incidence of any adverse events in treatment with rofecoxib compared with placebo (P = 0.922). CONCLUSIONS: In this study, once-daily treatment with 25 mg rofecoxib, a cyclooxygenase 2-specific inhibitor, significantly decreased the number and size of rectal polyps in familial adenomatous polyposis patients. 相似文献
116.
117.
Asha Padar Ubaradka G Sathyanarayana Makoto Suzuki Riichiroh Maruyama Jer-Tsong Hsieh Eugene P Frenkel John D Minna Adi F Gazdar 《Clinical cancer research》2003,9(13):4730-4734
PURPOSE: Loss or abnormal expression of Cyclin D2, a crucial cell cycle-regulatory gene, has been described in human cancers; however, data for prostate tumors are lacking. We investigated the epigenetic silencing of Cyclin D2 gene in prostate cancers and correlated the data with clinicopathological features. EXPERIMENTAL DESIGN: Cyclin D2 promoter methylation was analyzed in 101 prostate cancer samples by methylation-specific PCR. In addition, we analyzed 32 nonmalignant prostate tissue samples, which included 24 samples of benign disease, benign prostatic hypertrophy, or prostatitis and 7 normal tissues adjacent to cancer. The methylation status of Cyclin D2 was correlated with the methylation of nine other tumor suppressor genes published previously from our laboratory on the same set of samples (R. Maruyama et al., Clin. Cancer Res., 8: 514-519, 2002). The methylation index was determined as a reflection of the methylated fraction of the genes examined. RESULTS: The frequency of methylation of Cyclin D2 promoter was significantly higher in prostate cancers (32%) than in nonmalignant prostate tissues (6%; P = 0.004), and it was not age related. Aberrant methylation was present at insignificant levels in peripheral blood lymphocytes (8%). We also compared methylation of cyclin D2 with methylation of nine tumor suppressor genes [published previously from our laboratory (R. Maruyama et al., Clin. Cancer Res., 8: 514-519, 2002)] studied in the same set of samples. The concordances between methylation of Cyclin D2 and the methylation of RARbeta, GSTP1, CDH13, RASSF1A, and APC were statistically significant, whereas methylation of P16, DAPK, FHIT, and CDH1 were not significant. The differences in methylation index between malignant and nonmalignant tissues for all 10 genes were statistically significant (P < 0.0001). Among clinicopathological correlations, the high Gleason score group had significantly greater methylation frequency of Cyclin D2 (42%; P = 0.004). Although the high preoperative serum prostate-specific antigen (PSA) group did not have significantly greater methylation frequency, methylation of Cyclin D2 had higher mean PSA value. Also, the prostate cancers in the high Gleason score group had high mean values of PSA. CONCLUSIONS: Our results indicate that methylation of Cyclin D2 in prostate cancers correlates with clinicopathological features of poor prognosis. These findings are of biological and potential clinical importance. 相似文献
118.
Hirokatsu Kida Michiyoshi Taga Hiroshi Minaguchi Makoto Hanazono Tomoo Ohashi Teruyo Sakakura Moriaki Kusakabe 《Journal of assisted reproduction and genetics》1997,14(1):44-50
Purpose: Our aim was to examine the changes in spatiotemporal tenascin (TN) expression in mouse uterus during early pregnancy, when
the uterine tissue undergoes a tremendous restructuring.
Methods: Using immunohistochemistry and in situ hybridization, the changes in distribution of TN protein in mouse uterine tissues
in pregnancy Day 0 through Day 5 were analyzed.
Results: Immunoreactive TN and TN mRNA were expressed in the basement membrane of the epithelium as well as in the smooth muscle layer,
and their distribution shifted from the subbasement region on Day 0–3 to the smooth muscle layer on Days 4 and 5.
Conclusions: These results indicate that TN expression in the uterus during early pregnancy is spatiotemporally different and may be regulated
by a different mechanism. 相似文献
119.
Takashi Sekiguchi Makoto Noguchi Kenji Nakamori Gen-iku Kohama 《International journal of clinical oncology / Japan Society of Clinical Oncology》1997,2(1):21-28
Background Changes in interstitial collagen in human oral cancer have not yet been fully studied. We examined the relationship between
the degree of interstitial collagen deposition at the invading edge of the tumor, and the clinical and pathologic findings
in oral squamous cell carcinoma. We also investigated the therapeutic implication of the changes in distribution patterns
of collagen deposition by comparing biopsy specimens and surgical specimens.
Methods Immunohistochemical staining was performed by the streptavidin-biotin method using antibody against human type I collagen
for visualizing interstitial collagen in 50 biopsy and 45 surgical specimens.
Results Carcinomas with scanty interstitial collagen in biopsy specimens tended to have highly malignant characteristics. Large carcinomas
with scanty deposition both in biopsy and surgical specimens were likely to have positive resection margins in spite of radical
surgery.
Conclusion Immunostaining patterns for type I collagen of oral squamous cell carcinomas can provide information of importance in determining
safe resection margins. 相似文献
120.